Scorpius has designed ~8,000 sq. ft. of its contract biomanufacturing facility in San Antonio, Texas for mammalian cell culture and harvest, upstream and downstream processes, and formulation operations.
The facility’s multi-modal design contains seven cGMP-compliant controlled cleanrooms that utilize single-use systems to allow for greater flexibility, enhanced sterility assurance, and faster processing times with increased productivity.
Scorpius can support monoclonal antibody production, bi- and tri-specific products, antibody drug conjugates, allogeneic cell therapy products, as well as insect cell line derived products in this facility.
The mammalian leadership team has 100 years of industry experience working with mammalian expression systems, including CHO, NS0, 3T3, and HEK293 cell lines. Scorpius also has experience working with tissue culture, including stem-cell derived products.
US
